Utilization of membrane vesicle preparations to study drug-ABC transporter interactions

被引:54
作者
Glavinas, Hristos [1 ]
Mehn, Dora [1 ,2 ]
Jani, Marton [1 ]
Oosterhuis, Berend [1 ]
Heredi-Szabo, Krisztina [1 ,2 ]
Krajcsi, Peter [1 ]
机构
[1] Solvo Biotechnol, H-2040 Budaors, Hungary
[2] Solvo Biotechnol, H-6726 Szeged, Hungary
关键词
ABC transporter; ATPase assay; monolayer assay; nucleotide trapping assay; vesicular transport assay;
D O I
10.1517/17425255.4.6.721
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The last 15 years have marked an expansion in our understanding of how ABC transporters modulate the pharmacokinetic properties of drugs. Assays based on different membrane preparations were one of the first methods developed to study ABC transporters. Later, they turned out to be valuable tools to gain insight into the nature of drug-ABC transporter interactions. Objectives: Membranes prepared from different sources have been used and characterized; based on the biochemical characteristics of the transport process, a number of different assay types have been developed. Methods: This review focuses on the current experiences on how different membrane-based assays can be utilized in pharmaceutical R&D. Sources of membrane preparations, available assay types and correlation studies between different in-vitro and in-vivo methods are discussed. Results/conclusion: Membrane-based assays are valuable tools in drug discovery to characterize drug-ABC transporter interactions.
引用
收藏
页码:721 / 732
页数:12
相关论文
共 70 条
[61]   P-GLYCOPROTEIN IS STABLY INHIBITED BY VANADATE-INDUCED TRAPPING OF NUCLEOTIDE AT A SINGLE CATALYTIC SITE [J].
URBATSCH, IL ;
SANKARAN, B ;
WEBER, J ;
SENIOR, AE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (33) :19383-19390
[62]   MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine [J].
vanHelvoort, A ;
Smith, AJ ;
Sprong, H ;
Fritzsche, I ;
Schinkel, AH ;
Borst, P ;
van Meer, G .
CELL, 1996, 87 (03) :507-517
[63]  
Volk EL, 2003, CANCER RES, V63, P5538
[64]   Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2) [J].
Williamson, Gary ;
Aeberli, Isabelle ;
Miguet, Laurence ;
Zhang, Ziding ;
Sanchez, M.-Belen ;
Crespy, Vanessa ;
Barron, Denis ;
Needs, Paul ;
Kroon, Paul A. ;
Glavinas, H. ;
Krajcsi, Peter ;
Grigorov, Martin .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (08) :1262-1268
[65]   Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system [J].
Wu, CY ;
Benet, LZ .
PHARMACEUTICAL RESEARCH, 2005, 22 (01) :11-23
[66]   A 96-well efflux assay to identify ABCG2 substrates using a stably transfected MDCK II cell line [J].
Xiao, Yongling ;
Davidson, Ralph ;
Smith, Arthur ;
Pereira, Dennis ;
Zhao, Sabrina ;
Soglia, John ;
Gebhard, David ;
de Morais, Sonia ;
Duignan, David B. .
MOLECULAR PHARMACEUTICS, 2006, 3 (01) :45-54
[67]   Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2) [J].
Zelcer, N ;
Huisman, MT ;
Reid, G ;
Wieling, P ;
Breedveld, P ;
Kuil, A ;
Knipscheer, P ;
Schellens, JHM ;
Schinkel, AH ;
Borst, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23538-23544
[68]  
Zeng H, 2000, CANCER RES, V60, P4779
[69]   Mechanistic study on the intestinal absorption and disposition of baicalein [J].
Zhang, Li ;
Lin, Ge ;
Kovacs, Bernadette ;
Jani, Marton ;
Krajcsi, Peter ;
Zuo, Zhong .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 31 (3-4) :221-231
[70]  
1998, METHODS ENZYMOL, P292